Social Security’s future may be even more dire than expected as time is running out to shore up the program’s finances.
An analysis of late-stage trial data showed that 87% of patients who were treated with the combination of Tecvayli and Darzalex Faspro as early as the second line were estimated to have comparable ...
The proof-of-concept clinical study of IMVT-1402 in CLE was a randomized, double-blind, placebo-controlled, global trial that assessed the safety and efficacy of IMVT-1402 in adult patients with CLE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results